封面
市場調查報告書
商品編碼
1691808

血液製劑市場 - 全球產業規模、佔有率、趨勢、機會和預測,按產品、類型、應用區域和競爭細分,2020-2030 年

Blood Preparation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Application Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球血液製劑市場價值為 435.7 億美元,預計到 2030 年將達到 625.7 億美元,預測期內複合年成長率為 6.22%。全球血液製備市場是醫療保健和製藥行業一個充滿活力且至關重要的組成部分,涵蓋廣泛的產品和服務,旨在確保各種醫療應用中血液和血液相關產品的可用性和安全性。該市場圍繞著血液成分、血漿和其他血液衍生物的加工、測試和分銷,對於救命的輸血、治療和研究至關重要。隨著對病人安全的日益重視,對先進、高品質的血液製備產品和服務的需求也穩步成長。

市場概況
預測期 2026-2030
2024 年市場規模 435.7 億美元
2030 年市場規模 625.7 億美元
2025-2030 年複合年成長率 6.22%
成長最快的領域 血液衍生物
最大的市場 北美洲

主要市場促進因素

慢性病盛行率

主要市場挑戰

嚴格遵守法規

主要市場趨勢

血液製備技術的進步

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第4章:全球血液製劑市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品(全血、血液成分、血液衍生物)
    • 按類型(血小板聚集抑制劑、纖維蛋白溶解劑、抗凝血劑)
    • 依用途分類(血栓形成、肺栓塞、腎功能不全、心絞痛血管併發症、其他)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖
    • 按產品
    • 按類型
    • 按應用
    • 按地區

第5章:亞太血液製劑市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品
    • 按類型
    • 按應用
    • 按國家
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章:歐洲血液製劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章:北美血液製劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 墨西哥
    • 加拿大

第 8 章:南美洲血液製劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第9章:中東和非洲血液製劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章:市場動態

  • 驅動程式
  • 挑戰

第 11 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 12 章:全球血液製劑市場:SWOT 分析

第 13 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章:競爭格局

  • Pfizer, Inc.
  • Bristol-Myers Squibb Company
  • Leo Pharma A/S
  • Sanofi
  • Xiamen Hisunny Chemical Co., LTD
  • AstraZeneca plc
  • Baxter International Inc
  • Portola Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Shandong East Chemical Industry Co.

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20728

Global Blood Preparation Market was valued at USD 43.57 billion in 2024 and is expected to reach USD 62.57 billion by 2030 with a CAGR of 6.22% during the forecast period. The Global Blood Preparation Market is a dynamic and critical component of the healthcare and pharmaceutical industry, encompassing a wide range of products and services aimed at ensuring the availability and safety of blood and blood-related products for various medical applications. This market revolves around the processing, testing, and distribution of blood components, plasma, and other blood derivatives, vital for life-saving transfusions, therapeutic treatments, and research. With a growing emphasis on patient safety, the demand for advanced and high-quality blood preparation products and services has been steadily increasing.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 43.57 Billion
Market Size 2030USD 62.57 Billion
CAGR 2025-20306.22%
Fastest Growing SegmentBlood Derivatives
Largest MarketNorth America

Key Market Drivers

Prevalence of Chronic Diseases

The prevalence of chronic diseases is a primary driver behind the rapid growth of the Global Blood Preparation Market. Chronic diseases, which encompass a wide range of conditions such as cancer, anemia, hemophilia, and blood disorders, often necessitate frequent blood transfusions as an integral part of their management and treatment. This demand for blood and blood-related products is escalating due to the increasing global burden of chronic diseases.

As populations age and lifestyles become increasingly sedentary, the incidence of chronic diseases continues to rise. Conditions like diabetes, cardiovascular diseases, and cancer have become more common, leading to a growing need for blood preparations. For instance, cancer patients often require regular blood transfusions to manage the anemia and low platelet counts associated with chemotherapy, while individuals with blood disorders like sickle cell anemia depend on blood transfusions to alleviate their symptoms and complications.

Key Market Challenges

Stringent Regulatory Compliance

The Global Blood Preparation Market, a crucial pillar of healthcare, faces a formidable challenge in the form of stringent regulatory compliance. While regulations are essential to ensuring the safety and efficacy of blood and blood-related products, the stringent nature of these requirements can impede the market's growth and operational efficiency.

Blood preparation involves a complex set of processes, from collection and testing to storage and distribution. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), set stringent standards that must be met to guarantee the safety and quality of blood products. These standards encompass numerous facets of the blood preparation process, including donor eligibility criteria, testing protocols, documentation, and the maintenance of storage and transportation conditions.

Meeting these rigorous regulatory requirements can be a resource-intensive endeavor, particularly for smaller blood banks and healthcare providers. Compliance demands substantial investments in state-of-the-art equipment, quality control measures, staff training, and infrastructure. These expenses can be cost-prohibitive for smaller organizations, potentially limiting their ability to participate in the market. Furthermore, the constant need to adapt to evolving regulations places an ongoing financial burden on stakeholders within the blood preparation industry.

Key Market Trends

Technological Advancements in Blood Preparation

Technological advancements in blood preparation are playing a pivotal role in boosting the Global Blood Preparation Market. Automation, sophisticated equipment, and innovative methods have ushered in a new era of efficiency, safety, and quality within the industry. These advancements are reshaping the landscape of blood collection, processing, and storage, leading to an enhanced market with numerous benefits for healthcare providers and patients alike.

Automation, in particular, stands out as a game-changer in the field. Automated blood preparation systems have revolutionized the industry by significantly reducing human error, enhancing precision, and accelerating the speed at which blood components can be prepared. Automated equipment can process large volumes of blood with unmatched precision, resulting in a more consistent and reliable supply of blood products. This not only improves operational efficiency but also reduces the margin of error, ensuring that the final products meet the highest quality and safety standards.

Moreover, innovative methods and technologies have paved the way for more advanced testing and screening processes. The introduction of nucleic acid testing (NAT), for instance, has significantly enhanced the sensitivity and accuracy of detecting infectious agents, such as HIV, hepatitis B and C. This improvement in blood safety has instilled greater confidence among healthcare professionals and the public, reassuring them that blood products are less likely to transmit infections or other complications.

Key Market Players

  • Pfizer, Inc.
  • Bristol-Myers Squibb Company
  • Leo Pharma A/S
  • Sanofi
  • Xiamen Hisunny Chemical Co., LTD
  • AstraZeneca plc
  • Baxter International Inc
  • Portola Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Shandong East Chemical Industry Co.

Report Scope:

In this report, the Global Blood Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Preparation Market, By Product:

  • Whole Blood
  • Blood Components
  • Blood Derivatives

Blood Preparation Market, By Type:

  • Platelet Aggregation Inhibitors
  • Fibrinolytics
  • Anticoagulants

Blood Preparation Market, By Application:

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others

Blood Preparation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Preparation Market.

Available Customizations:

Global Blood Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Blood Preparation Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product (Whole Blood, Blood Components, Blood Derivatives)
    • 4.2.2. By Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants)
    • 4.2.3. By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others)
    • 4.2.4. By Region
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Product
    • 4.3.2. By Type
    • 4.3.3. By Application
    • 4.3.4. By Region

5. Asia Pacific Blood Preparation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Type
    • 5.2.3. By Application
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Blood Preparation Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product
        • 5.3.1.2.2. By Type
        • 5.3.1.2.3. By Application
    • 5.3.2. India Blood Preparation Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product
        • 5.3.2.2.2. By Type
        • 5.3.2.2.3. By Application
    • 5.3.3. Australia Blood Preparation Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product
        • 5.3.3.2.2. By Type
        • 5.3.3.2.3. By Application
    • 5.3.4. Japan Blood Preparation Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product
        • 5.3.4.2.2. By Type
        • 5.3.4.2.3. By Application
    • 5.3.5. South Korea Blood Preparation Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product
        • 5.3.5.2.2. By Type
        • 5.3.5.2.3. By Application

6. Europe Blood Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Blood Preparation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Germany Blood Preparation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Spain Blood Preparation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
    • 6.3.4. Italy Blood Preparation Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Type
        • 6.3.4.2.3. By Application
    • 6.3.5. United Kingdom Blood Preparation Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Type
        • 6.3.5.2.3. By Application

7. North America Blood Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Blood Preparation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
    • 7.3.2. Mexico Blood Preparation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
    • 7.3.3. Canada Blood Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application

8. South America Blood Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Blood Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
    • 8.3.2. Argentina Blood Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Colombia Blood Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application

9. Middle East and Africa Blood Preparation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Blood Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
    • 9.3.2. Saudi Arabia Blood Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
    • 9.3.3. UAE Blood Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Blood Preparation Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Pfizer, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Bristol-Myers Squibb Company
  • 14.3. Leo Pharma A/S
  • 14.4. Sanofi
  • 14.5. Xiamen Hisunny Chemical Co., LTD
  • 14.6. AstraZeneca plc
  • 14.7. Baxter International Inc
  • 14.8. Portola Pharmaceuticals, Inc.
  • 14.9. GlaxoSmithKline PLC
  • 14.10.Shandong East Chemical Industry Co.

15. Strategic Recommendations

16. About Us & Disclaimer